Walder Wyss team advised the funds managed by Pharmakon Advisors, LP.Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a global pharmaceutical company primarily focused on investigating experimental oral antioxidative…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
